- 【Updated on May 12, 2025】 Integration of CiNii Dissertations and CiNii Books into CiNii Research
- Trial version of CiNii Research Knowledge Graph Search feature is available on CiNii Labs
- Suspension and deletion of data provided by Nikkei BP
- Regarding the recording of “Research Data” and “Evidence Data”
Nonmyeloablative Bone Marrow Transplant from HLA-Identical Sibling for Chronic Granulomatous Disease
-
- ONO Mayuko
- Department of Pediatrics, Hiroshima University School of Medicine
-
- FUJITA Naoto
- Department of Pediatrics, Hiroshima Red Cross Hospital & Atomic-Bomb Survivors Hospital
-
- HAMAMOTO Kazuko
- Department of Pediatrics, Hiroshima Red Cross Hospital & Atomic-Bomb Survivors Hospital
-
- MIZUKAMI Tomoyuki
- Department of Pediatrics, Miyazaki Medical College, University of Miyazaki
-
- NUNOI Hiroyuki
- Department of Pediatrics, Miyazaki Medical College, University of Miyazaki
-
- KOBAYASHI Masao
- Department of Pediatrics, Hiroshima University School of Medicine
Bibliographic Information
- Other Title
-
- 慢性肉芽腫症に対するHLA一致同胞からの骨髄非破壊的同種骨髄移植
Search this article
Description
Chronic granulomatous disease (CGD) is an inherited disorder caused by the abnormalities of NADPH oxidase in phagocytic cells. Stem cell transplantation (SCT) from an HLA-identical donor is an effective treatment for patients with CGD. However, SCT with myeloablative conditioning carries a high incidence of serious complications and death. We report a 21-year-old man with CGD who was successfully treated with allogeneic bone marrow transplantation (alloBMT) from his HLA-identical brother following a nonmyeloablative conditioning regimen consisting of cyclophosphamide, fludarabine and a low dose of total body irradiation. Engraftment was rapidly achieved without any toxicity or complication. Partial donor chimerism following alloBMT was converted to complete donor chimerism and nomal oxidase activity of neutrophils was induced by several donor lymphocyte infusions (DLI) from his HLA-identical brother. At 30 months after transplant, the patient is in excellent clinical and hematological condition, maintaining complete chimerism. We suggest that alloBMT preceded by nonmyeloablative conditioning and followed by DLI may constitute a successful mode of therapy for patients with CGD.
Journal
-
- The Japanese Journal of Pediatric Hematology
-
The Japanese Journal of Pediatric Hematology 20 (1), 34-38, 2006
THE JAPANESE SOCIETY OF PEDIATRIC HEMATOLOGY/ONCOLOGY
- Tweet
Keywords
Details 詳細情報について
-
- CRID
- 1390282679318443264
-
- NII Article ID
- 130004117957
- 10017295857
-
- NII Book ID
- AN10080852
-
- ISSN
- 18844723
- 09138706
-
- Text Lang
- ja
-
- Data Source
-
- JaLC
- CiNii Articles
-
- Abstract License Flag
- Disallowed